Sectra has signed a five-year contract with North Tees and Hartlepool National Health System (NHS) Foundation Trust for the delivery of a regional digital pathology solution to the Northern Cancer Alliance in the U.K. The solution will span the 10 separate trusts of the consortium, and aims to improve cancer care workflows through enabling pathologists to instantly access and share images and information between departments and locations.

Fujifilm Medical Systems U.S.A. Inc. announced a nationwide awareness campaign titled ‘Aspire to Be Fearless’ focused on improving access to breast health education and mammography screening services for every woman that needs it, especially those most reluctant. At the center of the campaign, Fujifilm will be traveling around the U.S. with its ‘Aspire to Be Fearless’ mobile mammography coach to provide educational opportunities for clinicians, raise awareness about the importance of screening and will be providing mammograms to the underserved population in key locations.

IBA announced the physics team of University Medical Center Groningen (UMCG) in the Netherlands has developed and clinically implemented a novel automated treatment log-based patient quality assurance (QA) approach for proton therapy. This enables them to reduce the time needed for the in-beam measurement-based conventional patient QA.

SyntheticMR announced U.S. Food and Drug Administration (FDA) clearance for clinical use of its SyMRI Image and SyMRI Neuro product packages together with magnetic resonance imaging (MRI) systems from Siemens Healthineers.

M*Modal announced that the company and Community Health Network (CHNw) are collaborating to transform the patient-physician experience while improving provider and clinician satisfaction and care quality.

Ikonopedia will showcase its suite of structured breast reporting and Mammography Quality Standards Act (MQSA) management tools designed to improve reporting efficiency, and optimize facility operations at two upcoming radiology meetings. The company will be exhibiting at the Society for Imaging Informatics in Medicine (SIIM) annual meeting, June 26-28 in Aurora, Colo., and the Association for Medical Imaging Management (AHRA) annual meeting, July 21-25 in Aurora.

iCAD Inc. announced the launch of ProFound AI for 2D Mammography in Europe. This software is the latest addition to iCAD’s deep-learning, artificial intelligence (AI) platform and follows the launch of ProFound AI for Digital Breast Tomosynthesis (DBT), which was CE Marked in March 2018 and U.S. Food and Drug Administration (FDA)-cleared in December 2018. ProFound AI for 2D Mammography and ProFound AI for DBT will both be featured in the iCAD exhibition booth at the Société Française d'Imagerie de la FEMme (SIFEM) medical conference June 13-15, 2019, in Lille, France.

Three-dimensional (3-D) printing software and solutions company Materialise has received U.S. Food and Drug Administration (FDA) clearance for its Mimics Enlight cardiovascular planning software suite. The first release will support clinicians planning complex transcatheter mitral valve replacement (TMVR) procedures.


Editor’s note: This article is the third in a content series by Greg Freiherr covering the Society for Imaging Informatics in Medicine (SIIM) conference in June.


Subscribe Now